Eugene Fan: Dual-Model Explainability in Blood Cell Classification
Eugene Fan, Senior Consultant at Tan Tock Seng Hospital, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in PLOS Digital Health, adding:
“Delighted to share our newly published paper in PLOS Digital Health (Impact Factor 7.7): ‘Aligning deep learning and interpretable models for blood cell classification: A dual-model framework for explainability.’
Deep-learning systems can classify blood cells with remarkable accuracy, but their ‘black-box’ nature remains a barrier to clinical trust and adoption. In this study, we developed the dream framework, pairing a high-performing YOLO classifier with an interpretable Random Forest model that explains predictions using familiar morphological features such as cell size, nuclear shape, nuclear–cytoplasmic ratio, lobulation and colour.
The YOLO model correctly classified 99.84% of cells, while the interpretable model reproduced 98.91% of its predictions. Importantly, the explanations also showed 96.9% concurrence with the reasoning of haematologists and laboratory medical technologists.
For me, the key message is that accuracy in AI algorithms alone is not enough.
Clinical AI should also be able to show us why it has reached a decision, using concepts that us clinicians already recognize and understand.
Congratulations and sincere thanks to Magdalene C., Xinran XU, Li Rong Wang, Timothy Yeo, Hemalatha Shanmugam, Shu Ping Lim, Xiuyi Fan and everyone who contributed to this work.”
Title: Aligning deep learning and interpretable models for blood cell classification: A dual-model framework for explainability
Authors: Magdalene Yeok Yu Cheong, Xinran Xu, Li Rong Wang, Timothy Xiao Jing Yeo, Hemalatha Shanmugam, Shu Ping Lim, Bingwen Eugene Fan, Xiuyi Fan
Other posts featuring Eugene Fan on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?